Live News Categoriesequity

Cogent Biosciences, Inc. (COGT) News

Track canonical SquawkNews coverage tagged to COGT, Cogent Biosciences, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol COGT Asset equity Sector Markets 90 days 1 Last 37.935 Updated Jun 30, 2026, 12:04 PM UTC Open live news feed

L Cogent Biosciences Files New Drug Application To FDA For Bezuclastinib In Advanced Systemic Mastocytosis Cogent Biosciences, Inc. (Nasdaq: COGT ), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced it has submitted its New Drug Application (NDA) to the U.S. Fo REGULATION | Jun 30, 2026, 12:04 PM UTC